SWOG clinical trial number
SWOG-8304
Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast
Closed
Phase
Published
Abbreviated Title
Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast
Activated
05/27/1983
Closed
05/04/1984
Publication Information Expand/Collapse
1991
Phase II study of L-Alanosine (NSC-153353) in patients with advanced breast cancer. A Southwest Oncology Group study.